حول Kyowa Kirin International plc.
At the COMPANY, commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. COMPANY is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major western markets. COMPANY is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical company.